Cargando…

Interrelationship Between Health Insurance Status and Prostate Cancer Grade Can Have Critical Impact on Prostate Cancer Disease Control: A Retrospective Cohort Study

The extent to which prostate cancer (PCa) pathology interacts with health insurance to predict PCa outcomes remains unclear. This study will assess the overall association of health insurance on PCa disease control and analyze its interrelationship PCa pathology. A total of 674 PCa patients, treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Awasthi, Shivanshu, Gerke, Travis, Williams, Vonetta L., Asamoah, Francis, Fink, Angelina K., Balkrishnan, Rajesh, Park, Jong Y., Yamoah, Kosj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446254/ https://www.ncbi.nlm.nih.gov/pubmed/30935222 http://dx.doi.org/10.1177/1073274819837184

Ejemplares similares

African‐American men and prostate cancer‐specific mortality: a competing risk analysis of a large institutional cohort, 1989–2015
por: Williams, Vonetta L., et al.
Publicado: (2018)

ANPEP: A Potential Regulator of Tumor Cell—Immune Metabolic Interactions in Prostate Cancer of Men of African Descent
por: Elkenawi, Asmaa, et al.
Publicado: (2022)

Contemporary Radiation Treatment of Prostate Cancer in Africa: A Ghanaian Experience
por: Asamoah, Francis A., et al.
Publicado: (2018)

RF05 | PSUN358 ANPEP: A potential regulator of tumor cell - macrophage metabolic interactions in prostate cancer of African American men
por: Yamoah, Kosj, et al.
Publicado: (2022)

Definitive Radiation Treatment Patterns and Outcomes for Low and Intermediate Risk Prostate Cancer Patients: A Cross-Continental Comparative Study
por: Asamoah, Francis A., et al.
Publicado: (2019)

Proton beam therapy: clinical utility and current status in prostate cancer
por: Yamoah, Kosj, et al.
Publicado: (2016)

Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer
por: Berglund, Anders E., et al.
Publicado: (2018)

Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System
por: Yamoah, Kosj, et al.
Publicado: (2022)

A Proof-of-Concept Study on the Use of Prostate Artery Embolization Before Definitive Radiation Therapy in Prostate Cancer
por: Peacock, Jeffrey, et al.
Publicado: (2020)

Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer in Sub-Saharan Africa: A Retrospective Analysis of Recurrence and Survival in Women Treated for Breast Cancer at the Korle Bu Teaching Hospital in Ghana
por: Ayettey Anie, Hannah, et al.
Publicado: (2021)

BMI trajectories and risk of overall and grade‐specific prostate cancer: An observational cohort study among men seen for prostatic conditions
por: Wang, Kai, et al.
Publicado: (2018)

Early results of prostate cancer radiation therapy: an analysis with emphasis on research strategies to improve treatment delivery and outcomes
por: Yamoah, Kosj, et al.
Publicado: (2013)

Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race
por: Kensler, Kevin H., et al.
Publicado: (2022)

Clinicopathological significance of the EMT-related proteins and their interrelationships in prostate cancer. An immunohistochemical study
por: Parol-Kulczyk, Martyna, et al.
Publicado: (2021)

KLK3 SNP–SNP interactions for prediction of prostate cancer aggressiveness
por: Lin, Hui-Yi, et al.
Publicado: (2021)

Phase I dose escalation trial of stereotactic radiotherapy prior to robotic prostatectomy in high risk prostate cancer
por: Liveringhouse, Casey, et al.
Publicado: (2021)

The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer
por: Yamoah, Kosj, et al.
Publicado: (2016)

The impact of body mass index on dosimetric quality in low-dose-rate prostate brachytherapy
por: Echevarria, Michelle I., et al.
Publicado: (2016)

Prostatic Artery Embolization Is Safe and Effective for Medically Recalcitrant Radiation-Induced Prostatitis
por: Parikh, Nainesh, et al.
Publicado: (2020)

Trends in Gene Expression Profiling for Prostate Cancer Risk Assessment: A Systematic Review
por: Chen, Zhaoyi, et al.
Publicado: (2017)

Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors
por: Parra, Andres N., et al.
Publicado: (2018)

Non-Adaptive MR-Guided Radiotherapy for Prostate SBRT: Less Time, Equal Results
por: Sandoval, Maria L., et al.
Publicado: (2021)

Differential Expression of miRNAs Contributes to Tumor Aggressiveness and Racial Disparity in African American Men with Prostate Cancer
por: Ottman, Richard, et al.
Publicado: (2023)

miRNAs associated with prostate cancer risk and progression
por: Luu, Hung N., et al.
Publicado: (2017)

Insurance Approval for Definitive Proton Therapy for Prostate Cancer
por: Mendenhall, William M., et al.
Publicado: (2021)

The percentage of high‐grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death
por: Berney, Daniel M, et al.
Publicado: (2019)

Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors
por: Parra, N. Andres, et al.
Publicado: (2019)

Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences
por: Rayford, Walter, et al.
Publicado: (2021)

The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
por: Xiang, Yu-zhu, et al.
Publicado: (2013)

Association of statin use with risk of Gleason score‐specific prostate cancer: A hospital‐based cohort study
por: Wang, Kai, et al.
Publicado: (2019)

Grading of prostate cancer: a work in progress
por: Kweldam, C F, et al.
Publicado: (2018)

MRI grading for the prediction of prostate cancer aggressiveness
por: Boschheidgen, M., et al.
Publicado: (2021)

Clinical features and prognosis of prostate cancer with high-grade prostatic intraepithelial neoplasia
por: Lee, Donghyun, et al.
Publicado: (2015)

Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome
por: Berney, Daniel M, et al.
Publicado: (2016)

Low Prostate Concentration of Lycopene Is Associated with Development of Prostate Cancer in Patients with High-Grade Prostatic Intraepithelial Neoplasia
por: Mariani, Simone, et al.
Publicado: (2014)

New prostate cancer grade group system correlates with prostate cancer death in addition to biochemical recurrence
por: Epstein, Jonathan I
Publicado: (2016)

Comment on ‘Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome’
por: Dell'Oglio, Paolo, et al.
Publicado: (2017)

Relationship between Apparent Diffusion Coefficient Distribution and Cancer Grade in Prostate Cancer and Benign Prostatic Hyperplasia
por: Saito, Shigeyoshi, et al.
Publicado: (2022)

Surface Modification of Liposomes by a Lipopolymer Targeting Prostate Specific Membrane Antigen for Theranostic Delivery in Prostate Cancer
por: Yari, Hooman, et al.
Publicado: (2019)

Grade-dependent Response to Finasteride in Early Prostate Cancer
por: Rick, Ferenc G., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8387q1qa93o425v9trbm42tf9i